Abstract
This article gives a review of the regulation by the Russian law of the so-called ‘off-label’ use of medicinal drugs, that is the use of drugs outside their approved indication, information in data sheets and other known properties. The definition of the term ‘off-label’ is presented in details for which the understanding of the term in different countries is summarized. The discussion covers both off-label prescription and marketing practices. The article emphasizes the connection between the legal aspects of the off-label use and the model of national law regulation for providing legal services in general. The text culminates at an introduction of the new Russian legislative amendments granting more opportunities for off-label drug prescription.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
